CAS No. |
477953-07-4 |
|---|---|
中文名称 |
((31R,7aR,8R,8aR,11S,11aR,11bS))-8-乙基-11-甲基-十二氢氮杂卓并[3,2,1-hi]呋喃并[3,2-e]吲哚-10(2H)-酮 |
英文名称 |
(31R,7aR,8R,8aR,11S,11aR,11bS)-8-ethyl-11-methyldodecahydroazepino[3,2,1-hi]furo[3,2-e]indol-10(2H)-one |
别名 |
Neostenine;Furo[2,3-h]pyrrolo[3,2,1-jk][1]benzazepin-10(2H)-one, 8-ethyldodecahydro-11-methyl-, (7aR,8R,8aR,11S,11aR,11bS,11cR)- |
标准英文名 |
(31R,7aR,8R,8aR,11S,11aR,11bS)-8-ethyl-11-methyldodecahydroazepino[3,2,1-hi]furo[3,2-e]indol-10(2H)-one |
MDL No. |
MFCD20274570 |
分子式 |
C17H27NO2 |
分子量 |
277.41 |
精确分子量 |
277.20 |
SMILES |
CC[C@@H]1[C@H]2CCCCN3CC[C@@H]([C@H]4[C@@H]1OC(=O)[C@H]4C)[C@@H]23 |
标准SMILES |
C[C@H]1[C@@H]2[C@H](OC1=O)[C@H](CC)[C@H]1CCCCN3CC[C@@H]2[C@H]31 |
用途 |
Neostenine exhibits antitussive activity; it shows high absorptive permeability as a P-glycoprotein substrate in the Caco-2 monolayer model and demonstrates oral activity for intestinal applications. |
InChIKey |
ROIHYOJMCBKEER-FGBMJVKNSA-N |
|
|
评论 |
|---|